Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

External Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI): Strong Calibration in the Brazilian Prospective Hodgkin Lymphoma Registry

Blood (2023) 142 (Supplement 1): 6200.

https://doi.org/10.1182/blood-2023-173318

Published: 2023

Journal Articles

Development and Validation of the Early-Stage Hodgkin Lymphoma (HL) International Prognostication Index (E-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Andrew M Evens, Angie Mae Rodday, Matthew J. Maurer, Ranjana H. Advani, Marc Andre, Andrea Gallamini, Annette E. Hay, David Hodgson, Richard T. Hoppe, Martin Hutchings, Peter Johnson, Brian K. Link, Stephen Opat, John M. Raemaekers, Jenica Upshaw, Qingyan Xiang, Nicholas Counsell, Susan K Parsons, John Radford

Blood (2023) 142 (Supplement 1): 3058.

https://doi.org/10.1182/blood-2023-173320

Published: 2023

Journal Articles

Longitudinal Differences By Treatment Arm in Health-Related Quality of Life Among High Risk Pediatric Hodgkin's Lymphoma Patients Treated on the Children's Oncology Group Ahod 1331 Study

Annalynn M Williams, Angie Mae Rodday, Qinglin Pei, Tara O. Henderson, Frank Keller, Angela Punnett, Kara M. Kelly, Sharon M. Castellino, Susan K Parsons

Blood (2023) 142 (Supplement 1): 672.

https://doi.org/10.1182/blood-2023-187125

Published: 2023

Journal Articles

Age-Based Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI) in a Real-World Danish Study: Suboptimal Performance in Older Patients

Rasmus Rask Kragh Jørgensen, Sandra Eloranta, Jacob Haaber Christensen, Martin Hutchings, Rasmus Bo Dahl-Soerensen, Peter Kamper, Andrew M Evens, Matthew J. Maurer, Susan K Parsons, Angie Mae Rodday, Jenica Upshaw, Tarec Christoffer Christoffer El-Galaly, Lasse Hjort Jakobsen

Blood (2023) 142 (Supplement 1): 4455.

https://doi.org/10.1182/blood-2023-178498

Published: 2023

Journal Articles

Peripheral Neuropathy in Children with High Risk Hodgkin Lymphoma (HL): The Role of Protocol-Stipulated Dose Modification in the Children's Oncology Group (COG) AHOD1331 Study

Susan K. Parsons, Frank G. Keller, Qinglin Pei, Angie Mae Rodday, Jennifer Belsky, Yue Wu, Angela Punnett, Tara O Henderson, Kara M. Kelly, Sharon M. Castellino

Blood (2022) 140 (Supplement 1): 6550–6551.

https://doi.org/10.1182/blood-2022-167046

Published: 2022

Journal Articles

Development and Validation of the a dvanced-Stage H odgkin Lymphoma (HL) I nternational P rognostication I ndex (A-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Angie Mae Rodday, Susan K. Parsons, Jonathan W. Friedberg, Andrea Gallamini, Eliza Hawkes, David C. Hodgson, Peter Johnson, Brian K. Link, Eric Mou, Kerry J. Savage, Jenica Upshaw, Pier Luigi Zinzani, Matthew J. Maurer, Andrew M. Evens

Blood (2022) 140 (Supplement 1): 760–762.

https://doi.org/10.1182/blood-2022-164720

Published: 2022

Journal Articles

Prognostication for Advanced Stage Hodgkin Lymphoma (HL) in the Modern Era: A Project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Angie Mae Rodday, PhD, Susan K Parsons, MD MRP, Carlton Scharman, MD, Ranjana Advani, MD, Massimo Federico, MD, Jonathan W. Friedberg, MD MSSc, Andrea Gallamini, MD, David C. Hodgson, MD MPH, FRCPC, Peter Hoskin, MD, Martin Hutchings, MD PhD, Peter Johnson, MD FRCP, Kara M. Kelly, MD, Brian K. Link, MD, John A. Radford, MD FMedSci, Pier Luigi Zinzani, MD, James R. Cerhan, MD PhD, John Raemaekers, MD, Andrew M. Evens, DO,MMSc, On Behalf Of The HoLISTIC Consortium

Blood (2020) 136 (Supplement 1): 16–18.

https://doi.org/10.1182/blood-2020-135935

Published: 2020

Journal Articles

Patient and Disease Factors Predict Risk of 1-Year Mortality Among Older Adults Who Receive Intensive Chemotherapy for Hodgkin Lymphoma (HL)

Anita J Kumar, MDMS, Jason Nelson, MPH, Angie Mae Rodday, PhD, Andrew M. Evens, DO,MMSc, Jonathan W. Friedberg, MD MSSc, Tanya M. Wildes, MD MSCI, Susan K Parsons, MD MRP

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-140823

Published: 2020

Journal Articles

Treatment with Full Chemotherapy Regimens in Older Adults with Hodgkin Lymphoma Improves 3-Year Overall Survival, but Less Than Half Receive Full Regimens

Angie Mae Rodday, PhD, Theresa E. Hahn, PhD, Anita J Kumar, MDMS, Peter K Lindenauer, MD MSc, Jonathan W. Friedberg, MD, Andrew Matthew Evens, DO,MMSc, Susan K Parsons, MD MRP

Blood (2019) 134 (Supplement_1): 1563.

https://doi.org/10.1182/blood-2019-124141

Published: 2019

Journal Articles

Quantifying Social Disadvantage for Patients with Sickle Cell Disease: Implications for Quality of Care

Nicole Savidge, BA, Susan K Parsons, MD MRP, Daqin Mao, PhD, Ruth Ann Weidner, MBA, MRP, Kimberly S Esham, MD, Angie Mae Rodday, PhD MS

Blood (2018) 132 (Supplement 1): 317.

https://doi.org/10.1182/blood-2018-99-113558

Published: 2018

Journal Articles

Defining Sickle Cell Disease Severity Among Adults Hospitalized with Vaso-Occlusive Crisis

Kimberly S Esham, MD, Angie Mae Rodday, PhD, Nicole Savidge, BA, Daqin Mao, PhD, Ruth Ann Weidner, MBA, MRP, Susan K Parsons, MD MRP

Blood (2018) 132 (Supplement 1): 3577.

https://doi.org/10.1182/blood-2018-99-111717

Published: 2018

Journal Articles

Productivity Loss Among Parent Caregivers Is Associated with Poor Health-Related Quality of Life (HRQL) at the Intial Diagnosis of Pediatric Advanced Stage Hodgkin Lymphoma (HL)

Susan K Parsons, MD MRP, Sharon M. Castellino, MD MSc, Angie Mae Rodday, PhD, Frank G Keller, MD, Kara M. Kelly, MD, Rena M Conti, PhD, Debra Lerner, PhD MSc, Tara O. Henderson, MDMPH

Blood (2018) 132 (Supplement 1): 975.

https://doi.org/10.1182/blood-2018-99-117316

Published: 2018

Journal Articles

Hematopoietic Stem Cell Transplant Utilization in Relapsed/Refractory Hodgkin Lymphoma: A Population Level Analysis of Statewide Claims Data

Anem Waheed, MD MPH, Angie Mae Rodday, PhD MS, Anita J Kumar, MD MS, Kenneth B. Miller, MD, Susan K Parsons, MD MRP

Blood (2018) 132 (Supplement 1): 4771.

https://doi.org/10.1182/blood-2018-99-111921

Published: 2018

Journal Articles

Higher Socioeconomic Status Is Associated with Improved Overall Survival in Adults with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: A Population Study

Anita J Kumar, MD MS, Tobi Henzer, BS, Angie Mae Rodday, PhD MS, Marlise R. Luskin, MD, Wendy Stock, MD, Susan K Parsons, MD MRP

Blood (2018) 132 (Supplement 1): 4780.

https://doi.org/10.1182/blood-2018-99-114773

Published: 2018

Journal Articles

Opioid Utilization in Adults Hospitalized with Sickle Cell Pain Crises: An Understudied Population

Angie Mae Rodday, PhD, Kimberly S Esham, MD, Nicole S Savidge, BA, Daqin Mao, PhD, Ruth Ann Weidner, MBA, MRP, Susan K Parsons, MD MRP

Blood (2018) 132 (Supplement 1): 5884.

https://doi.org/10.1182/blood-2018-99-111386

Published: 2018

Journal Articles

The Development and Validation of an Electronic Health Record (EHR)-Based Algorithm for Identifying Treatment Failure in Newly Diagnosed Hodgkin Lymphoma (HL) Treated in a US Community Oncology Setting

Chun R Chao, PhD, Lanfang Xu, Nancy Cannizzaro, PhD, Angie Mae Rodday, PhD MS, Joseph Feliciano, PharmD, Anita J Kumar, MD MS, Andrew M. Evens, DO, MSc, Susan K Parsons, MD MRP

Blood (2018) 132 (Supplement 1): 2261.

https://doi.org/10.1182/blood-2018-99-112225

Published: 2018

Journal Articles

Health-Related Quality of Life (HRQL) Trajectories during Treatment for Advanced Stage Pediatric Hodgkin Lymphoma (HL)

Susan K Parsons, MD MRP, Angie Mae Rodday, PhD MS, Rizvan Bush, MS, Qinglin Pei, PhD, Anem Waheed, MD MPH, Frank G Keller, MD, Kara M. Kelly, MD, Tara O. Henderson, MD MPH, Sharon M. Castellino, MD MSc

Blood (2018) 132 (Supplement 1): 3587.

https://doi.org/10.1182/blood-2018-99-112664

Published: 2018

Journal Articles

Significantly Improved Long Term Health Related Quality of Life (HRQL) and Neurocognition Following Familial Haploidentical Stem Cell Transplantation (HISCT) Utilizing CD34 Enrichment and Mononuclear (CD3) Addback in High Risk Patients with Sickle Cell Disease (SCD)

Blood (2018) 132 (Supplement 1): 162.

https://doi.org/10.1182/blood-2018-162

Published: 2018

Journal Articles

Longer Length of Stay and No Chemotherapy Is Associated with Greater Likelihood of Death during Hospitalization in Patients with Diffuse Large B-Cell Lymphoma: An Analysis from the National Inpatient Sample (NIS)

Anita J. Kumar, MD, Tobi Henzer, Angie Mae Rodday, PhDMS, Susan K Parsons, MD MRP

Blood (2017) 130 (Supplement 1): 2121.

https://doi.org/10.1182/blood.V130.Suppl_1.2121.2121

Published: 2017

Journal Articles

Assessment of Health-Related Quality of Life in Adults Hospitalized with Sickle Cell Disease Vaso-Occlusive Crisis

Kimberly S Esham, MD, Angie Mae Rodday, PhD MS, Ruth Ann Weidner, MBA, MRP, Rachel J. Buchsbaum, MD, Hedy P Smith, MD PhD, Susan K Parsons, MD MRP

Blood (2017) 130 (Supplement 1): 2138.

https://doi.org/10.1182/blood.V130.Suppl_1.2138.2138

Published: 2017

NARROW

External Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI): Strong Calibration in the Brazilian Prospective Hodgkin Lymphoma Registry

Development and Validation of the Early-Stage Hodgkin Lymphoma (HL) International Prognostication Index (E-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Longitudinal Differences By Treatment Arm in Health-Related Quality of Life Among High Risk Pediatric Hodgkin's Lymphoma Patients Treated on the Children's Oncology Group Ahod 1331 Study

Age-Based Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI) in a Real-World Danish Study: Suboptimal Performance in Older Patients

Peripheral Neuropathy in Children with High Risk Hodgkin Lymphoma (HL): The Role of Protocol-Stipulated Dose Modification in the Children's Oncology Group (COG) AHOD1331 Study

Development and Validation of the a dvanced-Stage H odgkin Lymphoma (HL) I nternational P rognostication I ndex (A-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Prognostication for Advanced Stage Hodgkin Lymphoma (HL) in the Modern Era: A Project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Patient and Disease Factors Predict Risk of 1-Year Mortality Among Older Adults Who Receive Intensive Chemotherapy for Hodgkin Lymphoma (HL)

Treatment with Full Chemotherapy Regimens in Older Adults with Hodgkin Lymphoma Improves 3-Year Overall Survival, but Less Than Half Receive Full Regimens

Quantifying Social Disadvantage for Patients with Sickle Cell Disease: Implications for Quality of Care

Defining Sickle Cell Disease Severity Among Adults Hospitalized with Vaso-Occlusive Crisis

Productivity Loss Among Parent Caregivers Is Associated with Poor Health-Related Quality of Life (HRQL) at the Intial Diagnosis of Pediatric Advanced Stage Hodgkin Lymphoma (HL)

Hematopoietic Stem Cell Transplant Utilization in Relapsed/Refractory Hodgkin Lymphoma: A Population Level Analysis of Statewide Claims Data

Higher Socioeconomic Status Is Associated with Improved Overall Survival in Adults with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: A Population Study

Opioid Utilization in Adults Hospitalized with Sickle Cell Pain Crises: An Understudied Population

The Development and Validation of an Electronic Health Record (EHR)-Based Algorithm for Identifying Treatment Failure in Newly Diagnosed Hodgkin Lymphoma (HL) Treated in a US Community Oncology Setting

Health-Related Quality of Life (HRQL) Trajectories during Treatment for Advanced Stage Pediatric Hodgkin Lymphoma (HL)

Significantly Improved Long Term Health Related Quality of Life (HRQL) and Neurocognition Following Familial Haploidentical Stem Cell Transplantation (HISCT) Utilizing CD34 Enrichment and Mononuclear (CD3) Addback in High Risk Patients with Sickle Cell Disease (SCD)

Longer Length of Stay and No Chemotherapy Is Associated with Greater Likelihood of Death during Hospitalization in Patients with Diffuse Large B-Cell Lymphoma: An Analysis from the National Inpatient Sample (NIS)

Assessment of Health-Related Quality of Life in Adults Hospitalized with Sickle Cell Disease Vaso-Occlusive Crisis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only